<bill session="103" type="h" number="4212" updated="2010-04-19T10:07:31-04:00">
	<state datetime="1994-04-14">REFERRED</state>
	<status><introduced datetime="1994-04-14"/></status>

	<introduced datetime="1994-04-14"/>
	<titles>
		<title type="short" as="introduced">Biotechnology Stimulus Act of 1994</title>
		<title type="official" as="introduced">To stimulate the research and development of biotechnologies.</title>
	</titles>
	<sponsor id="401547"/>
	<cosponsors>
		<cosponsor id="400160" joined="1994-05-09"/>
		<cosponsor id="400091" joined="1994-05-09"/>
		<cosponsor id="400124" joined="1994-04-14"/>
		<cosponsor id="400524" joined="1994-06-08"/>
		<cosponsor id="400117" joined="1994-05-09"/>
		<cosponsor id="400057" joined="1994-06-08"/>
		<cosponsor id="409627" joined="1994-05-09"/>
		<cosponsor id="410887" joined="1994-05-09"/>
	</cosponsors>
	<actions>
		<action datetime="1994-04-14"><text>Referred to the House Committee on Ways and Means.</text></action>
		<action datetime="1994-04-21"><text>Sponsor introductory remarks on measure. (CR H2590)</text></action>
	</actions>
	<committees>
		<committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Income tax"/>
		<term name="Accounting"/>
		<term name="Biotechnology"/>
		<term name="Business"/>
		<term name="Business losses"/>
		<term name="Capital gains tax"/>
		<term name="Corporation taxes"/>
		<term name="Costs"/>
		<term name="Economic policy"/>
		<term name="Employee stock options"/>
		<term name="Finance"/>
		<term name="Indexing (Economic policy)"/>
		<term name="Labor"/>
		<term name="Profit"/>
		<term name="Research and development"/>
		<term name="Research and development tax credit"/>
		<term name="Restricted stock options"/>
		<term name="Science policy"/>
		<term name="Stocks"/>
		<term name="Tax deductions"/>
		<term name="Tax exclusion"/>
		<term name="Taxation"/>
		<term name="Technology"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	4/14/1994--Introduced.
Biotechnology Stimulus Act of 1994 - Amends the Internal Revenue Code with regard to the biotechnology research credit to: (1) establish an alternative credit calculation based on aggregate research expenses; and (2) make the credit permanent. Establishes: (1) a biotechnology variable capital gains deduction; and (2) a capital gains exclusion for biotechnology startup business stock held for more than two years. Provides for the indexing of certain capital assets for purposes of gain or loss determinations. Expresses the sense of the Congress that accounting standards should not be changed to require that biotechnology businesses deduct the value of stock options from their profits.

	</summary>
</bill>
